The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Peptides with Dual Antimicrobial and Anticancer Activities
Open accessAbstract
In recent years, the number of people suffering from cancer and multi-resistant infections has increased, such that both diseases are already seen as current and future major causes of death. Moreover, chronic infections are one of the main causes of cancer, due to the instability in the immune system that allows cancer cells to proliferate. Likewise, the physical debility associated with cancer or with anticancer therapy itself often paves the way for opportunistic infections. It is urgent to develop new therapeutic methods, with higher efficiency and lower side effects. Antimicrobial peptides (AMPs) are found in the innate immune system of a wide range of organisms. Identified as the most promising alternative to conventional molecules used nowadays against infections, some of them have been shown to have dual activity, both as antimicrobial and anticancer peptides (ACPs). Highly cationic and amphipathic, they have demonstrated efficacy against both conditions, with the number of nature-driven or synthetically designed peptides increasing year by year. With similar properties, AMPs that can also act as ACPs are viewed as future chemotherapeutic drugs, with the advantage of low propensity to resistance, which started this paradigm in the pharmaceutical market. These peptides have already been described as molecules presenting killing mechanisms at the membrane level, but also acting toward intracellular targets, which increases their success compartively to one-target specific drugs. This review will approach the desirable characteristics of small peptides that demonstrated dual activity against microbial infections and cancer, as well as the peptides engaged in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,263
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Studies on anticancer activities of antimicrobial peptides
Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296
Hancock, R. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80051-7 · Cited by 1,096
Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge
Arias, C. A., & Murray, B. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0804651 · Cited by 1,027
The immunology of host defence peptides: beyond antimicrobial activity
Hancock, R. E. W., Haney, E. F., & Gill, E. E. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.29 · Cited by 945
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
Drusano, G. L. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro862 · Cited by 930
Park, C. B., Kim, H. S., & Kim, S. C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8159 · Cited by 896
From antimicrobial to anticancer peptides. A review
Gaspar, D., Veiga, A. S., & Castanho, M. A. R. B. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00294 · Cited by 749
A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs
Gordon, Y. J., Romanowski, E. G., & McDermott, A. M. (2005) · Current Eye Research · doi:10.1080/02713680590968637 · Cited by 697
Approaches for enhancing oral bioavailability of peptides and proteins
Renukuntla, J., Vadlapudi, A. D., Patel, A., Boddu, S. H. S., & Mitra, A. K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.030 · Cited by 681 · cited 2×
“the preferred mode for drug delivery, corresponding to approximately 60% of the administration routes used for drugs (Renukuntla et al., 2013).”
BackgroundAnimal antimicrobial peptides: An overview
Andreu, D., & Rivas, L. (1998) · Biopolymers · doi:10.1002/(sici)1097-0282(1998)47:6<415::aid-bip2>3.0.co;2-d · Cited by 618
Chen, Y., Mant, C. T., Farmer, S. W., Hancock, R. E. W., Vasil, M. L., & Hodges, R. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413406200 · Cited by 600
Cationic amphiphilic peptides with cancer-selective toxicity
Schweizer, F. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.043 · Cited by 517
Arnold, M., Karim-Kos, H. E., Coebergh, J. W., Byrnes, G., Antilla, A., Ferlay, J., Renehan, A. G., Forman, D., & Soerjomataram, I. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2013.09.002 · Cited by 513
Host defense peptides as new weapons in cancer treatment
Papo, N., & Shai, Y. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4560-2 · Cited by 501
Oral Delivery of Peptide Drugs: Barriers and Developments
Hamman, J. H., Enslin, G. M., & Kotz??, A. F. (2005) · BioDrugs · doi:10.2165/00063030-200519030-00003 · Cited by 499
Cancer Treatment Using Peptides: Current Therapies and Future Prospects
Thundimadathil, J. (2012) · Journal of Amino Acids · doi:10.1155/2012/967347 · Cited by 491
Multiple Drug Resistance Mechanisms in Cancer
Baguley, B. C. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9321-2 · Cited by 478
Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment
Mader, J. S., & Hoskin, D. W. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.8.933 · Cited by 430
Riedl, S., Zweytick, D., & Lohner, K. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.09.004 · Cited by 405
The therapeutic applications of antimicrobial peptides (AMPs): a patent review
Kang, H.-K., Kim, C., Seo, C. H., & Park, Y. (2017) · Journal of Microbiology · doi:10.1007/s12275-017-6452-1 · Cited by 386
Antibiotic resistance: The last resort
McKenna, M. (2013) · Nature · doi:10.1038/499394a · Cited by 360
de la Fuente-Núñez, C., Reffuveille, F., Mansour, S. C., Reckseidler-Zenteno, S. L., Hernández, D., Brackman, G., Coenye, T., & Hancock, R. E. W. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.01.002 · Cited by 323
In Silico Models for Designing and Discovering Novel Anticancer Peptides
Tyagi, A., Kapoor, P., Kumar, R., Chaudhary, K., Gautam, A., & Raghava, G. P. S. (2013) · Scientific Reports · doi:10.1038/srep02984 · Cited by 320
Peptide-based cancer therapy: Opportunity and challenge
Wu, D., Gao, Y., Qi, Y., Chen, L., Ma, Y., & Li, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.002 · Cited by 306
Rozek, T., Wegener, K. L., Bowie, J. H., Olver, I. N., Carver, J. A., Wallace, J. C., & Tyler, M. J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01536.x · Cited by 288
Di Mario, S., Basevi, V., Lopalco, P. L., Balduzzi, S., D’Amico, R., & Magrini, N. (2015) · Journal of Immunology Research · doi:10.1155/2015/435141 · Cited by 257
Huang, Y.-B., Wang, X.-F., Wang, H.-Y., Liu, Y., & Chen, Y. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0811 · Cited by 224
Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide
Lee, H. S., Park, C. B., Kim, J. M., Jang, S. A., Park, I. Y., Kim, M. S., Cho, J. H., & Kim, S. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.041 · Cited by 188
Anticancer β-Hairpin Peptides: Membrane-Induced Folding Triggers Activity
Sinthuvanich, C., Veiga, A. S., Gupta, K., Gaspar, D., Blumenthal, R., & Schneider, J. P. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210569f · Cited by 175
Dennison, S., Whittaker, M., Harris, F., & Phoenix, D. (2006) · Current Protein & Peptide Science · doi:10.2174/138920306779025611 · Cited by 168
Peptide-Based Treatment: A Promising Cancer Therapy
Xiao, Y.-F., Jie, M.-M., Li, B.-S., Hu, C.-J., Xie, R., Tang, B., & Yang, S.-M. (2015) · Journal of Immunology Research · doi:10.1155/2015/761820 · Cited by 163
Accelerating resistance, inadequate antibacterial drug pipelines and international responses
Theuretzbacher, U. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.12.006 · Cited by 157
Hilchie, A. L., Doucette, C. D., Pinto, D. M., Patrzykat, A., Douglas, S. E., & Hoskin, D. W. (2011) · Breast Cancer Research · doi:10.1186/bcr3043 · Cited by 156
Bevers, E. M., Comfurius, P., & Zwaal, R. F. A. (1996) · Lupus · doi:10.1177/096120339600500531 · Cited by 155
Infections in immunocompromised hosts and organ transplant recipients: Essentials
Fishman, J. A. (2011) · Liver Transplantation · doi:10.1002/lt.22378 · Cited by 151
Cancer Therapeutics- Opportunities, Challenges and Advances in Drug Delivery
Kakde, D. D., Kakde, R. B., Patil, A., Jain, D., & Shrivastava, V. (2011) · Cited by 126
Lincke, C. R., van der Bliek, A. M., Schuurhuis, G. J., der Velde-Koerts, T. V., Smit, J. J., & Borst, P. (1990) · PubMed · Cited by 120
Paredes‐Gamero, E. J., Martins, M. N. C., Cappabianco, F. A. M., Ide, J. S., & Miranda, A. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.02.015 · Cited by 118
Novel Antimicrobial Peptides Derived from Flatfish Genes
Patrzykat, A., Gallant, J. W., Seo, J.-K., Pytyck, J., & Douglas, S. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2464-2470.2003 · Cited by 118
Wang, K., Yan, J., Zhang, B., Song, J., Jia, P.-F., & Wang, R. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.12.027 · Cited by 110
The spectrum of pulmonary infections in cancer patients
Rolston, K. V. I. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200107000-00002 · Cited by 107
Antibacterial Activity of Human Neutrophil Defensin HNP-1 Analogs without Cysteines
Varkey, J., & Nagaraj, R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4561-4566.2005 · Cited by 99
Mansour, S., Pletzer, D., de la Fuente‐Núñez, C., Kim, P., Cheung, G. Y. C., Joo, H., Otto, M. J., & Hancock, R. E. W. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.09.015 · Cited by 89
Chemoprevention of Breast Cancer by Tamoxifen: Risks and Opportunities
Smith, L. L., Brown, K., Carthew, P., et al. (2000) · Critical Reviews in Toxicology · doi:10.1080/10408440008951120 · Cited by 80
Rational Design of Alpha‐Helical Antimicrobial Peptides: Do's and Don'ts
Uggerhøj, L. E., Poulsen, T. J., Munk, J. K., Fredborg, M., Søndergaard, T. E., Frimodt‐Møller, N., Hansen, P. B., & Wimmer, R. (2014) · ChemBioChem · doi:10.1002/cbic.201402581 · Cited by 80
McKeown, S., Lundy, F. T., Nelson, J., Lockhart, D., Irwin, C. R., Cowan, C. G., & Marley, J. J. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2005.11.005 · Cited by 76
Nishimura, M., Abiko, Y., Kurashige, Y., Takeshima, M., Yamazaki, M., Kusano, K., Saitoh, M., Nakashima, K., Inoue, T., & Kaku, T. (2004) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2004.07.001 · Cited by 75
Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics
Gaspar, D., Freire, J. M., Pacheco, T. R., Barata, J. T., & Castanho, M. A. R. B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.11.006 · Cited by 74
Human α-defensin-1 inhibits growth of human lung adenocarcinoma xenograft in nude mice
Xu, N., Wang, Y., Pan, W., Xiao, B., Wen, Y., Chen, X., Chen, L., Deng, H., You, J., Kan, B., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0010 · Cited by 71
The interactions of aurein 1.2 with cancer cell membranes
Dennison, S. R., Harris, F., & Phoenix, D. A. (2006) · Biophysical Chemistry · doi:10.1016/j.bpc.2006.12.009 · Cited by 65
Intratumoral Expression of Mature Human Neutrophil Peptide-1 Mediates Antitumor Immunity in Mice
Wang, Y., Li, D., Shi, H., Wen, Y., Yang, L., Xu, N., Chen, X., Chen, X., Chen, P., Li, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0484 · Cited by 65
Lan, Y., Lam, J. T., Siu, G. G., Yam, W. C., Mason, A. J., & Lam, J. K. W. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.08.001 · Cited by 61
Prediction of Antibacterial Activity from Physicochemical Properties of Antimicrobial Peptides
Melo, M. N., Ferré, R., Feliu, L., Bardají, E., Planas, M., & Castanho, M. A. R. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028549 · Cited by 60
Multiple Infections and Cancer: Implications in Epidemiology
Vedham, V., Divi, R. L., Starks, V. L., & Verma, M. (2013) · Technology in Cancer Research & Treatment · doi:10.7785/tcrt.2012.500366 · Cited by 60
Multidimensional Design of Anticancer Peptides
Lin, Y., Lim, Y. F., Russo, E., Schneider, P., Bolliger, L., Edenharter, A., Altmann, K., Halin, C., Hiss, J. A., & Schneider, G. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201504018 · Cited by 40
Domalaon, R., Findlay, B., Ogunsina, M. O., Arthur, G., & Schweizer, F. (2016) · Peptides · doi:10.1016/j.peptides.2016.07.007 · Cited by 39
Kelly, G., Kia, A. F.-A., Hassan, F., O’Grady, S., Morgan, M. P., Creaven, B. S., McClean, S., Harmey, J. H., & Devocelle, M. C. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob01815g · Cited by 37
Acute bacterial infection negatively impacts cancer specific survival of colorectal cancer patients
Attiê, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.13930 · Cited by 36
Kao, C. C., Lin, X., Yi, G., Zhang, Y., Rowe‐Magnus, D. A., & Bush, K. (2016) · mBio · doi:10.1128/mbio.01418-16 · Cited by 27
Bacteriophages Displaying Anticancer Peptides in Combined Antibacterial and Anticancer Treatment
Dąbrowska, K., Kaźmierczak, Z., Majewska, J., Miernikiewicz, P., Piotrowicz, A., Wietrzyk, J., Lecion, D., Hodyra‐Stefaniak, K., Nasulewicz‐Goldeman, A., Owczarek, B., et al. (2014) · Future Microbiology · doi:10.2217/fmb.14.50 · Cited by 25
BTM-P1 polycationic peptide biological activity and 3D-dimensional structure
Segura, C., Guzmán, F., Salazar, L. M., Patarroyo, M. E., Ordúz, S., & Lemeshko, V. V. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.113 · Cited by 23
Cited by
Anand, U., Dey, A., Chandel, A. K. S., Sanyal, R., Mishra, A., Pandey, D. K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.02.007 · Cited by 1,834
Kumar, P., Kizhakkedathu, J., & Straus, S. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,227
Biomimetic peptide self-assembly for functional materials
Levin, A., Hakala, T. A., Schnaider, L., Bernardes, G. J. L., Gazit, E., & Knowles, T. P. J. (2020) · Nature Reviews Chemistry · doi:10.1038/s41570-020-0215-y · Cited by 853
Peptide Design Principles for Antimicrobial Applications
Torres, M. D. T., Sothiselvam, S., Lu, T. K., & de la Fuente-Nunez, C. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.12.015 · Cited by 438
Application of Light Scattering Techniques to Nanoparticle Characterization and Development
Carvalho, P. M., Felício, M. R., Santos, N. C., Gonçalves, S., & Domingues, M. M. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00237 · Cited by 402
Self-citation
Metadata
- Authors
- Felício, M. R., Silva, O. N., Gonçalves, S., Santos, N. C., & Franco, O. L.
- Venue
- Frontiers in Chemistry
- Publisher
- Frontiers Media SA
- Published
- 2017-02-21
- Volume
- 5
- Pages
- 5-5
- ISSN
- 2296-2646 (ISSN-L)
- OpenAlex
- W2591017015
- Cited by
- 393
- References
- 65
- FWCI
- 26.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.